SEC Filing

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Laureles Saul R.

(Last)

(First)

(Middle)

5599 SAN FELIPE - 17TH FLOOR

(Street)

HOUSTON

77056

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/20/2016

3. Issuer Name and Ticker or Trading Symbol
SCHLUMBERGER LTD /NV/ [ SLB ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Deputy General Counsel, Corp.

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, $0.01 Par Value Per Share	1,690	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Incentive Stock Option (Right to Buy)	01/21/2011⁽¹⁾	01/21/2020	Common Stock, $0.01 Par Value Per Share	500	68.505	D
Incentive Stock Option (Right to Buy)	10/21/2011⁽²⁾	10/21/2020	Common Stock, $0.01 Par Value Per Share	1,588	64.225	D
Incentive Stock Option (Right to Buy)	01/19/2013⁽³⁾	01/19/2022	Common Stock, $0.01 Par Value Per Share	1,799	72.11	D
Incentive Stock Option (Right to Buy)	01/17/2014⁽⁴⁾	01/17/2023	Common Stock, $0.01 Par Value Per Share	2,519	73.25	D
Incentive Stock Option (Right to Buy)	04/16/2015⁽⁵⁾	04/16/2024	Common Stock, $0.01 Par Value Per Share	800	100.555	D
Incentive Stock Option (Right to Buy)	07/17/2015⁽⁶⁾	07/17/2024	Common Stock, $0.01 Par Value Per Share	170	114.825	D
Incentive Stock Option (Right to Buy)	04/16/2016⁽⁷⁾	04/16/2025	Common Stock, $0.01 Par Value Per Share	1,090	91.74	D
Incentive Stock Option (Right to Buy)	01/21/2017⁽⁸⁾	01/21/2026	Common Stock, $0.01 Par Value Per Share	1,614	61.92	D
Nq Stock Option (Right to Buy) W/ Tandem Tax W/h Right	10/21/2011⁽²⁾	10/21/2020	Common Stock, $0.01 Par Value Per Share	12	64.225	D
Nq Stock Option (Right to Buy) W/ Tandem Tax W/h Right	01/19/2013⁽³⁾	01/19/2022	Common Stock, $0.01 Par Value Per Share	601	72.11	D
Nq Stock Option (Right to Buy) W/ Tandem Tax W/h Right	01/17/2014⁽⁴⁾	01/17/2023	Common Stock, $0.01 Par Value Per Share	3,081	73.25	D
Nq Stock Option (Right to Buy) W/ Tandem Tax W/h Right	04/16/2015⁽⁵⁾	04/16/2024	Common Stock, $0.01 Par Value Per Share	3,200	100.555	D
Nq Stock Option (Right to Buy) W/ Tandem Tax W/h Right	07/17/2015⁽⁶⁾	07/17/2024	Common Stock, $0.01 Par Value Per Share	5,830	114.825	D
Nq Stock Option (Right to Buy) W/ Tandem Tax W/h Right	04/16/2016⁽⁷⁾	04/16/2025	Common Stock, $0.01 Par Value Per Share	6,910	91.74	D
Nq Stock Option (Right to Buy) W/ Tandem Tax W/h Right	01/21/2017⁽⁸⁾	01/21/2026	Common Stock, $0.01 Par Value Per Share	8,386	61.92	D

Explanation of Responses:

1. Became exercisable in five equal annual installments beginning January 21, 2011.

2. Became exercisable in five equal installments beginning October 21, 2011.

3. Became exercisable in five equal installments beginning January 19, 2013.

4. Became exercisable in five equal annual installments beginning January 17, 2014.

5. Became exercisable in five equal installments beginning April 16, 2015.

6. Became exercisable in five equal installments beginning July 17, 2105.

7. Became exercisable in five equal annual installments beginning April 16, 2016.

8. Will become exercisable in five equal annual installments beginning January 21, 2017.

	/s/Matthew Rinegar, attorney-in-fact for Saul R. Laureles	04/22/2016
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

The undersigned, in his capacity as a director or
officer, or both, of Schlumberger Limited, a Curacao
corporation (the "Company"), does hereby appoint each of
Matthew C. Rinegar and Lynda M. Quagliara, or either of them
acting singly, his/her true and lawful attorney-in fact
with full power of substitution, to (a) prepare, execute
in the undersigned's name and on the undersigned's behalf,
and submit to the U.S. Securities and Exchange Commission
(the "SEC") a Form ID, including amendments thereto, and
any other documents necessary or appropriate to obtain
codes, passwords and passphrases enabling the undersigned
to make electronic filings with the SEC of reports
required by Section 16(a) of the Securities Exchange Act
of 1934, as amended (the "Exchange Act"), or any rule or
regulation of the SEC; and (b) execute for and on behalf
of the undersigned, in the undersigned's capacity as a
director or officer, or both, of the Company, Forms 3, 4
and 5 in accordance with Section 16 of the Exchange Act,
as well as Forms 144, and complete and execute any
amendment or amendments thereto, and to file the same or
cause the same to be filed with the SEC.

	This Power of Attorney supersedes any and all prior
and existing powers of attorney signed by the undersigned
with respect to the subject matter hereof, and shall
remain in full force and effect until the undersigned is
no longer required to file Forms 3, 4, 5 or 144 with
respect to the undersigned's holdings of and transactions
in securities issued by the Company, unless earlier
revoked by the undersigned in a signed writing delivered
to the foregoing attorneys-in-fact.

April 22, 2016				/s/ Saul R. Laureles
					Saul R. Laureles